A PRESENTATION BY SECRETARY - CRISM _initiativesin_ism_for_national_global... · A PRESENTATION BY SECRETARY Department of AYUSH Ministry of Health Family Welfare New Delhi . 2 A

1

Government of IndiaMinistry of Health and Family Welfare

Department of AYUSH

www.indianmedicine.nic.in

A PRESENTATION BY

SECRETARY

Department of AYUSHMinistry of Health Family Welfare

New Delhi

2

A

Y

US

H

3

AYURVEDA

YOGA & NATUROPATHY

UNANI

SIDDHA

HOMOEOPATHY

DEPARTMENT OF AYUSH

A

Y

U

S

H

4

�Established in 1995 as ISM

�Renamed AYUSH in 2003.

Department of AYUSH

5

Department of AYUSH

National Medicinal Plant

Board

Research Councils, Laboratories, National Institutes,

CCIM / CCH

State AYUSH Directorates

6

� Aim - prevention of diseases & promotion of health

� Mainly based on herbal formulations, minerals and metals also used.

� Time tested safe and efficacious

� Charak Samhita and Sushrut Samhita written around1000 years B.C.

� “Sushruta” the father of surgery

Ayurveda

7

• Practiced in southern parts of India as

well as South Eastern Countries.

• Similarity with Ayurveda

• Herbo-mineral formulations

• Time tested

Siddha

8

Unani

• Originated in Greece and accepted in India

since 13th century

• Similarity with Ayurveda

• Mainly Herbal formulations

• Time tested

9

Yoga

• Yoga - as old as civilization

• The first archaeological evidence of Yoga found in stone seals excavated from the Indus Valley Civilization (3000 B.C).

• Aim - to promote Health, Harmony and

• Happiness

• Drug less therapy

10

Naturopathy

• Drug less, Non – invasive system of

therapy

• Natural materials used

• Based on theory of Vitality, Toxicemia,

Self-heating capacity of the body and

Principles of Healthy living.

11

Status of ISM in India

• Education and practice of ASU&H regulated by autonomous Regulatory Authorities.

• Manufacture for sale of ASU&H drugs regulated by Indian Drugs & Cosmetics Act, 1940 and Rules, 1945.

• Good Manufacturing Practices (GMP) enforced in 2003.

12

• Teaching Institutions 485 289

• Students Admission Capacity 25,000 32815

• No. of Regd. Practitioners. 6,00,000 725190

• Drug Manufacturing Units 9,000 9000 (Aprox.)

• Hospitals 3,192 11289

• Hospital beds in Govt. sector 60,237 494510

• Dispensaries 21,376 Data not available

Source – Annual Report of the Ministry of Health and Family Welfare.

ISM Vs Modern Medicine

Infrastructure

13

14

Research

Collaborative Research

with foreign Institutes

� CRISM

� University of Middlesex

�St. Petersberg - CCRAS

•Intra Mural Research

•Extra Mural Research

•GTP – genomics based

research transdisciplinary

15

Areas of strength of Ayurvedic Medicine

where recent research has yielded leads

� Antistress and Neuro Active Drugs

� Immunomodulators and Adaptogens

� Antiarthritic Drugs

� Life Style Diseases

� Anti Diabetics

� Panchakarma and Ksharsutra Treatment

16

ISM Trade profile

• World market of herbal medicine- $ 80 Billion

• By 2050 herbal market is expected to reach US $

5 trillion. (Report of task force Deptt. of commerce Dec

08).

• India’s export : $31.48 million (2007-08) EXIM Bank data

• The US herbal medicine consumption - $ 17

billion in the year 2000. (CURRENT SCIENCE, VOL. 93, NO. 10, 25 November 1356 MBER 2007)

17

Components of Ayurveda and Unani Medicines

• Herbal : 90-95 %

• Minerals : 1-2 %

• Metals : 1-2 %

• Animal Products : 1-2 %

• Marine Products : 1-2 %

These are used in single and multiple ingredients

formulations

18

Drug Development and

Manufacturing

• Drugs & Cosmetics Act, 1940 regulates

manufacture of ASU medicines

• Pharmacopoeia Committees set up to

lay down Pharmacopoeial standards.

• Implementation of GMP

Interface with bilateral &

Multilateral forums

WHO IRCH

AYUSH

informati

on on

IRCH

website

Other

Countries

• India- EU

Dialogue

• SAARC

• BIMSTEC

•ASEAN

• IBSA

• Russia

• China

APTMNE

T

Launching

of India’s

web-portal

a.Implementation of

WHO Country

Cooperation strategy

(2006-2011) by AYUSH

Research Councils

b.Placement of AYUSH

Consultants in WHO

offices.

a.Developing WHO

collaborating centres for

AYUSH

19

MoUs

1. China

2 International Trade Center, Geneva

Malaysia, UAE, EU, ASEAN, SAARC,

Chile, Hungary, Iran, Latvia and Armenia

MoUs Signed

MoUs Proposed

Countries / Organisation

20

AYUSH in Public Health

• Integrate and mainstream ISM in health care delivery system.

• Co-locate ISM facilities with those of Modern Medicine hospital - choice of treatment to the patient.

• Over 4000 ISM practitioners posted at /PHCs / CHCs/ DHs.

• Drug kit expanded to include Ayurveda, Siddha and Unani drugs having proven efficacy.

21

AYUSH in Public Health contd..

• Public Health Campaigns on:

� Ksharsutra for Anorectal disorder

� Quality Assurance for ASU drugs

� Geriatric Care through Ayurveda

� Mother and Child Care through Homoeopathy

� Ayurveda for management of Anaemia in women

� Unani for Skin Disorders

� Yoga for Mental Health

22

National Medicinal Plant Board

– Coordinate the development of medicinal plants sector.

– Conservation & Cultivation, Quality Control of medicinal plants.

– Prioritized 32 medicinal plants for large-scale cultivation.

23

Issues

Education Research

� Upscale

trans-

disciplinary

research

� Linkages

with modern

Science

institutions

Trade

• Inda-EU

Dialogue on

THMPD

• Free Trade

Agreement

with

neighbouring

countries

Drug Quality

�GMP

�WHO, EU GMP

� PPP e.g. with

QCI

� Sensitise

industry

�Consumer

awareness

�Quality

Certification

�Upgradation of

standards

�Accreditation

abroad

Mainstreaming

• 4000 AYUSH

Doctors

posted in

PHCs/ CHCs/

DHs

• Co-location

24

• Accreditation of AYUSH education & practice

abroad

• Developing collaborative research projects with

foreign institutes

• Addressing tariff /non-tariff barriers

• Harmonization of pharmacopoeial standards.

• Scientific understanding of Heavy metals.

Issues

25

Issues contd..

• Publication of research studies in reputed

journals

• Classical ASU medicines to be excluded from the requirement of geno-toxicity data.

• Quality and Safety should be based on the holistic effect.

26

TKDL

• Prevent Misappropriation of Indian Traditional

Knowledge– Break Format & Language barriers

• For International Patent Offices only

• Multilingual (French, German, Japanese, English

& Spanish)

• Conditions for Grant of Patents

– Prior Art

– Novelty

– Non Obviousness

27

TKDL current status

Transcriptions

� Ayurveda : 81,000

� Unani : 1,09,000

� Siddha : 12,000

� TKDL Yoga initiated

TKDL can safeguard 2,01,200 medicinal formulations

like Neem and turmeric in Ayurveda ,Unani and Siddha

which are present in 30 million A4 size pages, at

International Level.

28

Problem -Misappropriation of Indian Medicinal

Knowledge at International Patent Offices

• India successfully fought the invalidation of patents on wound healing property of Turmeric at USPTO & antifungal property of Neem at EPO

• Invalidation of turmeric patent took 3 years and Neem patent took 10 years

29

• Access Agreement with EPO concluded.

• Access of TKDL to EPO examiners would have direct impact on at least 48 pipe line TK based patent applications at EPO (Would not be granted)

• Negotiations are under way with USPTO for access - at least 40 TK based patent applications (Would not be granted)

Status of Negotiations with EPO &

USPTO

30

AYUSH

Univ. of MS

(NCNPR)

CRISM

CSIR (IIIM)

31

To facilitate scientific validation and

dissemination of information on Indian

systems of medicines [ISM] through

collaborative research.

CRISM - Mission

32

� To undertake research and developmental on potentials of the

traditional systems and latest scientific advances for promotion and

scientific acceptance of Indian systems of medicine and the products

thereof

� To encourage and facilitate cooperation for research activities

between the Indian and US academic and industrial institutions

� To facilitate dialogue between scientific community and

regulatory bodies of the two countries

� To provide and promote authentic information about the

strengths of Indian systems of medicine - demystify misconceptions

Goals

33

THANK YOU